Savaria Corp. Earnings Call Signals Structural Upside

Savaria Corp. ((TSE:SIS)) has held its Q4 earnings call. Read on for the main highlights of the call.

Savaria Corp. struck an upbeat tone on its latest earnings call, highlighting record quarterly and full‑year profitability, accelerating margin gains, and rapid deleveraging. Management acknowledged a few manageable headwinds, including European softness, FX volatility, and a temporary CapEx spike, but stressed that structural efficiencies from its Savaria One program are driving sustainable improvements and supporting a robust growth agenda.

Record Profitability and Margin Breakthroughs

Savaria reported adjusted EBITDA of $51.3 million in Q4, its best quarter ever, up about 20% year over year and delivering a 21.2% margin, 200 basis points higher than last year. For 2025, sales reached $913 million and adjusted EBITDA came in at $186.2 million with a 20.4% margin, surpassing the company’s 20% target and setting new annual records.

Top-Line Growth and Healthier Revenue Mix

Fourth‑quarter revenue rose to $241.8 million, an increase of $18.4 million or 8.3% versus the prior year. Management credited 5.2% organic growth as the primary engine, complemented by a 2.5% foreign exchange tailwind and a 0.6% lift from acquisitions, mainly the Western Elevator deal.

Accessibility and Patient Care Segment Momentum

Accessibility continued to anchor the story, with Q4 revenue up 7.7%, driven by 7.2% growth in North America and 9% in Europe, where organic growth finally turned positive. Patient Care revenue grew 10% in the quarter and roughly 5% for the full year, underscoring steady but uneven demand in that business line.

Margin Expansion Across Business Lines

Companywide gross margin improved to 38.9% from 37.7% last year, while operating income jumped 36.6%, reflecting both pricing discipline and operational gains. Segment profitability was strong, with Accessibility delivering an adjusted EBITDA margin of 23.4% and Patient Care reaching 19.4%, both pointing to solid operating leverage.

Cash Generation Fuels Rapid Deleveraging

Savaria produced $35 million of operating cash flow in Q4, enabling aggressive debt reduction and a stronger balance sheet. Net debt fell by $71 million year over year, bringing the leverage ratio down to just 1.03, as the company repaid $45.2 million of debt in Q4 and $75.2 million over 2025.

Savaria One Transformation Drives Structural Gains

Management emphasized that the Savaria One transformation program is now a core growth engine, not a temporary fix, with more than 160 initiatives executed in 2025 and roughly 35 rolled out in Q4 alone. These projects are generating recurring savings and process improvements that management describes as structural and sustainable, with over 100 new initiatives slated for 2026.

M&A Capacity and Strategic Tuck-In Deals

With about $312 million of available liquidity and leverage barely above 1x, Savaria sees ample room for additional acquisitions while keeping net debt well below 2x EBITDA. Recent tuck‑ins, including Western Elevator and Baxter Residential Elevator, are expanding its dealer network and product offering, reinforcing a strategy of bite‑sized, synergistic deals.

CapEx Discipline Alongside R&D Commitment

Capital spending in 2025 totaled $22 million, or 2.4% of sales, with Q4 CapEx at $6.8 million, reflecting disciplined investment despite growth initiatives. Management expects CapEx to rise to roughly 2.5%–3% of sales in 2026 due to a one‑time expansion of the Greenville facility, then normalize back to about 2%–2.5% in 2027, while keeping R&D and intangibles at roughly half of normal CapEx with a 62‑person R&D team.

European Growth Headwinds and Market Reset

Europe has been a soft spot for nearly two years, as Savaria divested noncore activities, tightened partnership terms, and repriced contracts, willingly giving up some volumes to preserve profitability. Combined with choppy government subsidy programs in markets like France and Italy, this led to restrained growth, though Q4 organic growth in Europe has returned to the low single digits.

Foreign Exchange Volatility Hits Earnings Line

Currency movements were a mixed blessing, contributing a 2.5% tailwind to Q4 revenue growth but causing a drag below the operating line. The company booked an unrealized foreign exchange loss of $1.7 million in the quarter compared with a gain in the prior year, which added to finance cost volatility despite improving fundamentals.

Strategic and One-Off Costs Mask Underlying Strength

Reported profitability in Q4 was held back by $4.7 million of strategic initiative expenses tied to Savaria One consulting, the last quarter for these external fees. Another $1.8 million of optimization and one‑time costs also weighed on earnings, but management framed these as temporary, with the associated benefits expected to be ongoing.

Higher Finance Costs Despite Lower Debt Interest

Total finance costs climbed to $4.8 million in Q4 from $2.4 million a year earlier, largely due to FX and other non‑interest items, even as interest on long‑term debt fell by $1.3 million thanks to deleveraging. The result is a somewhat noisy finance line that obscures the underlying improvement in the company’s capital structure.

Patient Care Growth Remains Uneven

While Patient Care posted a healthy 10% revenue increase in Q4 and roughly 5% for the full year, management cautioned that this business will remain inherently lumpy. Large project timing and shifting government funding cycles can cause quarter‑to‑quarter swings, meaning investors should focus more on multi‑year trends than on single‑quarter prints.

Greenville Expansion Creates Near-Term CapEx Hump

Savaria is expanding its Greenville U.S. home‑elevator facility, a one‑time project scheduled to go live in Q4 2026 that will temporarily lift 2026 CapEx into the 2.5%–3% of sales range. Currently, Greenville accounts for roughly 35%–40% of Savaria’s domestic U.S. home‑elevator production, and management sees further scaling potential once the expansion is complete.

Tax Rate Normalization to Lift Effective Burden

The Q4 effective tax rate of about 17.5% benefited from one‑time adjustments that flattered net earnings and will not recur. Looking ahead, management expects the effective tax rate to normalize around 26%–26.5% for 2026, a shift that could modestly dampen bottom‑line growth compared with the unusually low rate booked in the latest quarter.

Forward Guidance and Strategic Outlook

Savaria held back on formal 2026 guidance, promising detailed five‑year targets at its April Investor Day, but it laid out clear directional signals for investors. The company expects a normalized tax rate in the mid‑20s, no share buybacks but a stable dividend, continued deleveraging with room to deploy about $200 million on M&A while keeping leverage below 2x, modestly higher 2026 CapEx for Greenville, and further margin expansion powered by more than 100 new Savaria One initiatives and operating leverage.

Savaria’s latest earnings call portrayed a company in control of its growth trajectory, balancing record profitability and leaner leverage with disciplined investment and targeted acquisitions. While Europe, FX swings, and tax normalization pose some friction, management’s focus on structural efficiency, selective M&A, and capacity expansion suggests the positive momentum seen in 2025 has room to run for shareholders watching the story unfold.